| Rafael A Pupo, MD | |
|
228 Billerica Rd, Chelmsford, MA 01824-3604 | |
| (978) 250-6010 | |
| (978) 244-6610 |
| Full Name | Rafael A Pupo |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Location | 228 Billerica Rd, Chelmsford, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093752685 | NPI | - | NPPES |
| 3186750 | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 70601 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Rafael A Pupo, MD 228 Billerica Rd, Chelmsford, MA 01824-3604 Ph: (978) 250-6010 | Rafael A Pupo, MD 228 Billerica Rd, Chelmsford, MA 01824-3604 Ph: (978) 250-6010 |
News Archive
Turing Pharmaceuticals AG, a privately-held biopharmaceutical company focused on developing and commercializing innovative treatments for serious diseases and conditions, today emphasizes the continued availability of Daraprim and cautions healthcare providers of proposed alternatives to Daraprim.
As part of its mission to bring high-quality healthcare services closer to patients, NYU Langone Health and Perlmutter Cancer Center have expanded the Lung Cancer Screening Program to more than a dozen additional locations throughout its network in Manhattan, Brooklyn, Queens, and on Long Island.
In a study published online by JAMA, Rafael Harpaz, M.D., M.P.H., of the U.S. Centers for Disease Control and Prevention, Atlanta, and colleagues analyzed data from the 2013 National Health Interview Survey to estimate the prevalence of self-reported immunosuppressed adults in the United States.
Growing evidence for the effectiveness of fecal microbiota transplants as a treatment for patients with recurrent bouts of Clostridium difficile (C.difficile) associated diarrhea is presented in three studies - including a long-term follow-up of colonoscopic fecal microbiota transplant (FMT) for recurrent C. difficile Infection that included 77 patients from five different states- unveiled today at the American College of Gastroenterology's (ACG) 76th Annual Scientific meeting in Washington, DC.
While it's too soon to use COVID-19 antibody testing to issue "immunity passports", antibody tests that are available today are good enough to inform decisions about public health and relaxing social distancing interventions, says an international group of infectious disease and public health experts in Science Immunology today.
› Verified 9 days ago
Dr. Khalil A Khatri, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 6 Courthouse Ln Unit 7, Chelmsford, MA 01824 Phone: 978-453-5559 Fax: 978-453-4459 | |
Dr. Caroline Bevona, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 228 Billerica Rd, Chelmsford, MA 01824 Phone: 978-250-6010 Fax: 978-244-6610 | |
Dr. Christine M Hayes, MD Dermatology Medicare: May Accept Medicare Assignments Practice Location: 33 Village Sq, Chelmsford, MA 01824 Phone: 978-244-0060 Fax: 978-244-2522 | |
Dr. Andrew David Simkin, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3 Village Sq, Chelmsford, MA 01824 Phone: 978-256-4151 Fax: 978-256-3987 | |
Dr. Michael Thomas Rosenbaum, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 6 Courthouse Ln, Chelmsford, MA 01824 Phone: 978-934-9294 Fax: 978-934-0056 |